On the Radar: Five high-value biotech stocks

Our new On the Radar report returns with fresh insights from Simos Simeonidis, PhD, Rodman & Renshaw's senior biotech analyst, who highlights biotech stocks which he believes will be good value

Nasdaq volatility delays IPO, Almirall pulls drug over price, Topotarget to merge as PDUFA nears

Welcome to this week's edition of our EuroBiotech Report, in which we have news of how the rise and fall of U.S. biotech and med tech stocks is shaping decisions in Europe.

Biotech VCs wager $1.1B in Q1, starting the year with a flurry of new deals

Venture investing in the biotech sector hit the $1.1 billion mark in the first quarter of the year--a surprisingly strong showing for what has generally been a quiet season in the U.S. industry.

Prosonix and Mylan Enter Into Global Licensing Agreement for Generic Versions of Inhaled Respiratory Products Flixotide® and Flovent®

OXFORD, UK, and PITTSBURGH, April 15, 2014 – Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, today announced that it...

The Norwegian pharmaceutical company Lytix Biopharma has decided to spin out an early-stage project that has potential within the treatment of dementia.

One of Lytix Biopharma's projects has potential within treatment of dementia. This theraputic area is not within the company's commercial strategy, and it has therefore been decided to start a...

Heart Metabolics Limited Launched in Ireland with $20 Million Series A Financing

DUBLIN, April 17, 2014 /PRNewswire/ -- Heart Metabolics Limited, a new Irish biotechnology company focused on development of drugs for cardio-metabolic diseases, has announced the completion of a $20...

Wilson Therapeutics Secures $40 Million Private Financing To Advance Late Stage Development Program For Wilson's Disease

STOCKHOLM, April 16, 2014 /PRNewswire/ -- Wilson Therapeutics , a biopharmaceutical company, today announced that it has closed a $40 million Series B financing co-led by new investors, Abingworth...

Lombard Medical Technologies PLC -- Adjournment of Court Hearing

London, UK, 14 April, 2014 - On 26 February 2014, Lombard Medical (AIM: LMT), published a circular setting out the Board of Directors' recommendations to, inter alia, reorganise the Lombard...

Foundation Medicine drops $150M follow-on; MicroLin ups range on IPO;

@FierceBiotech: AMRI plans to shutter an R&D shop to save cash. Story from FierceCRO | Follow @FierceBiotech @JohnCFierce: Pfizer, AstraZeneca back a new strategy for cancer drug R&D. Article...

Heart Metabolics Limited Launched in Ireland with $20 Million Series A Financing

DUBLIN, April 17, 2014 /PRNewswire/ -- Heart Metabolics Limited, a new Irish biotechnology company focused on development of drugs for cardio-metabolic diseases, has announced the completion of a $20...